Company Filing History:
Years Active: 2016
Title: Michelle Zawadski: Innovator in Pharmaceutical Compounds
Introduction
Michelle Zawadski is a notable inventor based in Cleveland, OH (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target serotonin receptors. Her work is essential in addressing various health conditions, including addiction, anxiety, and depression.
Latest Patents
Michelle Zawadski holds 1 patent related to a series of compounds known as thienylindole azepines. These compounds are designed for use in pharmaceutical compositions and serve as therapeutic agents. The invention focuses on the modulation of serotonin receptor (5-HT) activity, which is crucial for treating a range of disorders.
Career Highlights
Michelle is currently associated with Abt Holding Company, where she continues her innovative work in pharmaceutical research. Her expertise in developing serotonin receptor ligands has positioned her as a valuable asset in the industry.
Collaborations
Throughout her career, Michelle has collaborated with esteemed colleagues, including Michael J Robarge and John Joseph Harrington. These partnerships have enhanced her research and contributed to the advancement of her projects.
Conclusion
Michelle Zawadski's contributions to pharmaceutical innovations highlight her role as a leading inventor in her field. Her work on serotonin receptor compounds is paving the way for new therapeutic solutions.